# Effect of Oxytocin Antagonist on Reduction of Uterine Contractions

> **NCT01043120** · PHASE2 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 99 (actual)

## Conditions studied

- In Vitro Fertilisation (IVF) Treatment

## Interventions

- **DRUG:** Barusiban
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01043120
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-05
- **Final completion:** 2010-12
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2017-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01043120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01043120, "Effect of Oxytocin Antagonist on Reduction of Uterine Contractions". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01043120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*